'Discordant Dots': Why Phila. Zantac Judge Rejected Bid for His Recusal
In a footnote of his opinion, Judge Joshua Roberts wrote, “A more cynical view of the circumstances is that plaintiffs’ ...
CureVac: Latest GBM Data Bodes Well For Next Program Check Point
CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...
FDA Urges Guillain-Barré Syndrome Warning On Labels Of RSV Vaccines Abrysvo And Arexvy
The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...
J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)
In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...
Becker's Hospital Review1d
FDA mandates warnings for 2 RSV vaccines
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
Hosted on MSN3d
Moderna, Novavax Stocks Climb Pre-Market On Growing Bird Flu Concerns: Retail Engagement Soars
Shares of Moderna, Inc. and Novavax, Inc. jumped premarket Tuesday, rising as much as about 6% and nearly 8%, respectively, ...
Nature4y
How GlaxoSmithKline is advancing efficient drug development in haematologic malignancies
At GlaxoSmithKline, we never lose sight of the fact that patients are at the core of what we do and that millions of lives are impacted by cancer. The patient’s voice is at the heart of our ...
moneycontrol.com1d
GlaxoSmithKline Pharmaceuticals
24 Jul, 2018 11 Sep, 2018 1:1 For every 1 share held; Holder will receive 1 bonus shares. 28 Sep, 1994 02 Jan, 1995 1:1 For every 1 share held; Holder will receive 1 bonus shares. 23 Jun, 1980-1:3 ...
Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight
Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., ...
Wall Street Journal4y
GlaxoSmithKline Pharmaceuticals Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...